Journal of gastrointestinal and liver diseases : JGLD最新文献

筛选
英文 中文
Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study. 恩格列净促进糖尿病肝硬化难治性腹水患者的钠尿:一项概念验证研究
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6897
Rongya Shi, Yuan Gao, Yunyi Gao, Longzhen Zhou, Wei Qin, Feng Zhao, Jianru Jia, Zhongjie Hu
{"title":"Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study.","authors":"Rongya Shi, Yuan Gao, Yunyi Gao, Longzhen Zhou, Wei Qin, Feng Zhao, Jianru Jia, Zhongjie Hu","doi":"10.15403/jgld-6897","DOIUrl":"10.15403/jgld-6897","url":null,"abstract":"<p><strong>Background and aims: </strong>Interventional studies directly targeting natriuresis in refractory cirrhotic ascites are scarce, and no prospective study has examined whether sodium-glucose transporter 2 (SGLT2) inhibitor-induced glucosuria is associated with changes in renal sodium handling. We conducted a randomized, open-label, proof-of-concept study to characterize the short-term natriuretic response to empagliflozin in patients with diabetes and refractory ascites Methods: Adults with type 2 diabetes, decompensated cirrhosis, and refractory ascites were randomized 1:1 to empagliflozin 10 mg once daily plus standard care or standard care alone for 10 days. The primary outcome was the between-group difference in mean change in fractional excretion of sodium (FENa, %) from baseline (Day 0) to the mean of post-baseline Days 1, 3, 7, and 10, estimated using a linear mixed-effects model. Key secondary outcomes included 24-hour urinary sodium excretion, 24-hour urine volume, and mean daily paracentesis volume.</p><p><strong>Results: </strong>Twenty-one participants were randomized (empagliflozin n=10; control n=11). In the empagliflozin group, the between-group difference in mean change in FENa from baseline to the post-baseline mean (days 1, 3, 7, and 10) was +0.44 percentage points (95%CI: 0.05-0.83; p=0.029). Empagliflozin increased 24-hour urinary sodium excretion by +92.1 mmol/24 h (95%CI: 47.1-137.2) and 24-hour urine volume by + 822 mL/24 h (95%CI: 403-1240) versus control. Mean daily paracentesis volume was 0.6 ± 0.4 L/day with empagliflozin and 1.3 ± 0.6 L/day with control (mean difference -0.70 L/day, 95%CI: -1.17 to -0.23). No serious adverse events occurred.</p><p><strong>Conclusions: </strong>In this open-label, proof-of-concept study, empagliflozin was associated with improved short-term natriuretic indices over 10 days in diabetic patients with decompensated cirrhosis and refractory ascites, without serious adverse events. Larger, blinded, longer-term trials are warranted to confirm these preliminary findings.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"393-399"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare endogenous hepatic penetrating injury. 罕见的内源性肝穿透性损伤。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6684
Yaomeng Chen, Wei Weng
{"title":"Rare endogenous hepatic penetrating injury.","authors":"Yaomeng Chen, Wei Weng","doi":"10.15403/jgld-6684","DOIUrl":"10.15403/jgld-6684","url":null,"abstract":"<p><p></p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"493-494"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric cracked and cobblestone-like mucosa associated with long-term proton pump inhibitor use. 胃破裂和鹅卵石样粘膜与长期使用质子泵抑制剂有关。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6891
Akiko Hokama, Ryosaku Tomiyama, Akira Hokama
{"title":"Gastric cracked and cobblestone-like mucosa associated with long-term proton pump inhibitor use.","authors":"Akiko Hokama, Ryosaku Tomiyama, Akira Hokama","doi":"10.15403/jgld-6891","DOIUrl":"https://doi.org/10.15403/jgld-6891","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"496-497"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Coding and Non-Coding Genomic Landscape of Hepatocellular Carcinoma: Etiological Risk Factors and their Current Clinical Implications. 肝细胞癌的编码和非编码基因组景观:病因危险因素及其当前的临床意义。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7552
Ana Maria Ciurdorean, Paul Chiroi, Daniel Gabriel Cosma, Mihai Dumitru Porojan, Ioana Rusu, Stefan Strilciuc, Ioana Berindan-Neagoe, Nadim Al Hajjar
{"title":"The Coding and Non-Coding Genomic Landscape of Hepatocellular Carcinoma: Etiological Risk Factors and their Current Clinical Implications.","authors":"Ana Maria Ciurdorean, Paul Chiroi, Daniel Gabriel Cosma, Mihai Dumitru Porojan, Ioana Rusu, Stefan Strilciuc, Ioana Berindan-Neagoe, Nadim Al Hajjar","doi":"10.15403/jgld-7552","DOIUrl":"https://doi.org/10.15403/jgld-7552","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the most common liver malignancy and a leading cause of cancer mortality, with burden projected to rise substantially by 2040. Its poor prognosis reflects the timing of diagnosis: HCC develops silently against chronic liver disease, and six-monthly ultrasound with alpha-fetoprotein remains insensitive in the early stages. Two developments have reshaped molecular understanding of this heterogeneous cancer. Large-scale sequencing established that the somatic landscape is not etiology-agnostic. The driver hierarchy is dominated by TERT, TP53, and CTNNB1; exposure-specific mutational signatures; and structural events such as hepatitis B virus integration, all of which differ systematically by upstream cause. In parallel, a dense non-coding regulatory layer has been shown to intersect with the core processes of hepatocarcinogenesis. These layers have largely been reviewed in isolation. Here, we integrate them, organize the coding and non-coding genomic architecture of HCC by etiological risk factor, and appraise the contributions of each to clinical decision-making. Etiological patterning is asymmetric - well-established at the coding layer but not yet demonstrated at the non-coding layer, where assignments derive from single-etiology cohorts compared across studies, platforms, and normalization strategies. Cutting across both layers are convergent nodes shared by all causes, most clearly depletion of the hepatoprotective microRNA-122, a marker of convergence rather than specificity. We then assess the clinical interface: multi-analyte serum scores and methylation-based cell-free DNA now outperform ultrasound for early detection in prospective cohorts, yet none is guideline-endorsed, and no circulating non-coding RNA has reached prospective validation. The near-term clinical yield of this field lies in risk stratification, not molecularly guided therapy.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"455-468"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cecal Volvulus Presenting a Kidney-shaped Appearance with the Whirl Sign. 盲肠扭转呈肾状,有旋状征。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6728
Masayoshi Nagahama, Daijiro Kagawa, Akira Hokama
{"title":"Cecal Volvulus Presenting a Kidney-shaped Appearance with the Whirl Sign.","authors":"Masayoshi Nagahama, Daijiro Kagawa, Akira Hokama","doi":"10.15403/jgld-6728","DOIUrl":"https://doi.org/10.15403/jgld-6728","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"326"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenteric artery vasospasm in shock patient with high-output heart failure due to renal cell carcinoma bone metastasis: CT findings. 肾细胞癌骨转移所致高输出量心力衰竭休克患者肠系膜动脉血管痉挛的CT表现。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6874
Francesco Michele Ronza, Teresa Letizia Di Gennaro, Paola Gagliardi, Stefania Tamburrini, Giovanni Giordano
{"title":"Mesenteric artery vasospasm in shock patient with high-output heart failure due to renal cell carcinoma bone metastasis: CT findings.","authors":"Francesco Michele Ronza, Teresa Letizia Di Gennaro, Paola Gagliardi, Stefania Tamburrini, Giovanni Giordano","doi":"10.15403/jgld-6874","DOIUrl":"https://doi.org/10.15403/jgld-6874","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"325"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectal Prolapse-related Sealed-off Perforation Mimicking Advanced Rectal Cancer. 模拟晚期直肠癌的直肠脱垂相关封闭穿孔。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6716
Yeon Ji Kim
{"title":"Rectal Prolapse-related Sealed-off Perforation Mimicking Advanced Rectal Cancer.","authors":"Yeon Ji Kim","doi":"10.15403/jgld-6716","DOIUrl":"https://doi.org/10.15403/jgld-6716","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"327"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The "India ink sign" in the liver: chemical shift imaging findings in hepatic angiomyolipoma. 肝脏“墨迹征”:肝血管平滑肌脂肪瘤的化学移位影像学表现。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6979
Jun Obara, Akio Tamura, Kunihiro Yoshioka
{"title":"The \"India ink sign\" in the liver: chemical shift imaging findings in hepatic angiomyolipoma.","authors":"Jun Obara, Akio Tamura, Kunihiro Yoshioka","doi":"10.15403/jgld-6979","DOIUrl":"https://doi.org/10.15403/jgld-6979","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"500-501"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Perspectives on Climate Change and Sustainable Healthcare Practices: A Cross-Sectional Survey Study in Patients with Inflammatory Bowel Disease. 患者对气候变化和可持续医疗实践的看法:炎症性肠病患者的横断面调查研究。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6908
Dorien Oomkens, Lotte Hazeleger, Daniëlle Van der Horst, Marjolijn Duijvestein
{"title":"Patient Perspectives on Climate Change and Sustainable Healthcare Practices: A Cross-Sectional Survey Study in Patients with Inflammatory Bowel Disease.","authors":"Dorien Oomkens, Lotte Hazeleger, Daniëlle Van der Horst, Marjolijn Duijvestein","doi":"10.15403/jgld-6908","DOIUrl":"https://doi.org/10.15403/jgld-6908","url":null,"abstract":"<p><strong>Background and aims: </strong>In the management of inflammatory bowel disease (IBD), resource-intensive procedures, such as endoscopy and treatment with biologics, substantially increase the environmental footprint. Understanding patients' perceptions on sustainable healthcare is crucial to develop climate-friendly policies. We explored perspectives on climate change and healthcare in patients with IBD using a cross-sectional survey.</p><p><strong>Methods: </strong>A web-based questionnaire was distributed to the Crohn and Colitis Netherlands panel and shared on their social platforms. The questionnaire included 27 items covering climate-related knowledge, concerns, sustainable behavior, the healthcare system's role in climate change, opinions on sustainable treatment alternatives, demographics, and IBD history. Descriptive statistics were used to summarize patient characteristics and responses. Cluster analysis was performed to identify subgroups with similar perspectives.</p><p><strong>Results: </strong>The analysis included 498 responses. A majority (72.5%) expressed concerns about climate change and 78.1% engaged in sustainable behaviors. Whilst 58.4% of patients preferred not to receive background information on sustainability when choosing between treatments, 71.3% would opt for the most sustainable treatment, 85.7% support reusable medical materials, and 77.1% would be willing to adjust their current IBD treatment to a more sustainable option. Support for sustainable healthcare practices was more divided when measures involved personal inconvenience. We identified three clusters with varying perspectives on sustainable healthcare practices. In the cluster with the most positive perspective on climate-friendly healthcare, patients were more often higher-educated, had more baseline knowledge on climate change, and already made sustainable choices in their daily life.</p><p><strong>Conclusions: </strong>IBD patients are concerned about climate change and generally support sustainable healthcare practices, provided these do not compromise their health or cause personal inconvenience.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"363-369"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply. 回复。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7489
Naruaki Ogasawara
{"title":"Reply.","authors":"Naruaki Ogasawara","doi":"10.15403/jgld-7489","DOIUrl":"https://doi.org/10.15403/jgld-7489","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"502"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书